CXCR3 controls T-cell accumulation in fat inflammation (2014)
- Authors:
- Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
- Unidade: HU
- DOI: 10.1161/ATVBAHA.113.303133
- Subjects: TECIDO ADIPOSO; INFLAMAÇÃO; LINFÓCITOS; MACRÓFAGOS; OBESIDADE
- Language: Inglês
- Imprenta:
- Source:
- Título: Arteriosclerosis, Thrombosis, and Vascular Biology
- ISSN: 1524-4636
- Volume/Número/Paginação/Ano: v.34, n.7, p. 1374-1381, jul. 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ROCHA, Viviane Zorzanelli et al. CXCR3 controls T-cell accumulation in fat inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, v. 34, n. 7, p. 1374-1381, 2014Tradução . . Disponível em: https://doi.org/10.1161/ATVBAHA.113.303133. Acesso em: 19 fev. 2026. -
APA
Rocha, V. Z., Folco, E. J., Ozdemir, C., Sheikine, Y., Christen, T., Sukhova, G. K., et al. (2014). CXCR3 controls T-cell accumulation in fat inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, 34( 7), 1374-1381. doi:10.1161/ATVBAHA.113.303133 -
NLM
Rocha VZ, Folco EJ, Ozdemir C, Sheikine Y, Christen T, Sukhova GK, Tang EHC, Bittencourt MS, Santos RD, Luster AD, Cohen DE, Libby P. CXCR3 controls T-cell accumulation in fat inflammation [Internet]. Arteriosclerosis, Thrombosis, and Vascular Biology. 2014 ;34( 7): 1374-1381.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1161/ATVBAHA.113.303133 -
Vancouver
Rocha VZ, Folco EJ, Ozdemir C, Sheikine Y, Christen T, Sukhova GK, Tang EHC, Bittencourt MS, Santos RD, Luster AD, Cohen DE, Libby P. CXCR3 controls T-cell accumulation in fat inflammation [Internet]. Arteriosclerosis, Thrombosis, and Vascular Biology. 2014 ;34( 7): 1374-1381.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1161/ATVBAHA.113.303133 - Heart disease and stroke statistics-2019 update: a report From the American Heart Association
- The yield of downstream tests after exercise treadmill testing: a prospective cohort study
- Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit
- Coronary calcium score vs. computed tomography angiography as tools to stratify cardiovascular risk
- Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study
- Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit
- Impact of coronary remodeling on fractional flow reserve [letter]
- Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients
- Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis)
- Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA
Informações sobre o DOI: 10.1161/ATVBAHA.113.303133 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
